Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on January 24, 2017. The filing serves to announce the Company's financial performance for the fourth fiscal quarter and the full fiscal year ended December 31, 2016. The detailed financial data is contained within the press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the body of this 8-K document.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms that a press release detailing the fourth quarter and full-year results has been issued.
Guidance, Outlook, and Risks
The filing text does not include specific management commentary, forward-looking guidance, risk factors, or contingencies. The document explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 24, 2017) for actual revenue, net income, and cash flow figures.
- Verify the specific year-over-year and quarter-over-quarter performance metrics not listed in this summary.
- Confirm the Company's liquidity position and debt obligations as detailed in the full press release.
- Note that the registrant name in the filing is MRI Interventions, Inc., distinct from the metadata field "Clearpoint Neuro, Inc."